InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Appelhans Dannielle. Director active across 2 companies, notably Rubius Therapeutics, Inc.. Cumulatively, 5 reports have been recorded. Split: 2 buys · 1 sell. Total volume traded: €19k. Activity tracked since 24 February 2023. The latest transaction was filed on 8 December 2023 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
5 of 5 declarations